SECOND PART- TRENDS AND DEVELOPMENT OF SPECIFIC TELEHEALTH SECTORS

Sectoral legal advice for clients from the telemedicine sector requires from lawyers to constantly monitor the market in this sector and constantly expand their knowledge of market needs. It is the duty of every lawyer of KIEŁTYKA GŁADKOWSKI to be up-to-date with the sector of economic activity on which they provide legal services. Proper legal advice requires from lawyers to know the market practice of a given sector, and above all, knowledge of complex IT terminology and the basics of the pharmaceutical market.

I Telehealth trends’ perspectives

On the Telehealth Investment Trends we can have a look from different perspectives.

1. One of these perspectives is a funding perspective. In the 2^nd quarter of 2021 we can notice a funding record broken for the 4^th quarter in a row (from the 3^rd quarter of 2020). The deal count amounted 163 deals and the funding amounted 5,038 (in millions of dollars).
2. The continental differences. It is explicitly noticeable that European investment nearly quintupled QoQ to reach a record high of $915M. Asian investments almost halved, north American investment slightly increased but European made an incredible investment growth which might be a long-perspective tendency (especially regarding the COVID-19 pandemic and Europe’s ageing an increasingly digitalized society). Among these reasons and investment tendencies the polish executive in the abovementioned ordinance included the procedures to impart instructions about e- medical prescription realization, additional treatment, tests realization (including laboratory tests) and possibility to sign up an Online Patient Account[1]. These procedures and medical services requirements can be (and in deed will be for sure) unquestionably helpful for older people who are yet to learn with increasingly used IT systems.
3. The differences between early-, mid- and late- stage deal percentage. It is worthy to notice that in the 2021 early-stage deal share tracked at a historical low but at the same time the late-stage share at its high level (12% in comparison to previous 8%). This may reflect the increasing sophistication and maturity of the telehealth industry and of course the maturity and investment development and advancement of telehealth entities.

More

MEDICINE TELE-SECTORS- TELE-TECHNOLOGIES AND NEW OPPORTUNITIES FOR PATIENTS

Nowadays an issue like telehealth or telemedicine is not something abnormal, extraordinary or an extravagancy for richer part of the society. Moreover under circumstances of COVID-19 pandemic the telehealth sector became more known (thus in many countries telemedicine is a well-known medicine  and services sector) and, what is more relevant, it became one of the most (or even the most) crucial and indispensable way to communicate with the doctor and to take care of yourself.

Fast, easy to operate, straightforward and accessible for every internet and phone users telehealth expanded into our life and our health-life. It is a undoubtful fact that it is one of the most rapidly, dynamically, successfully branch of economy, especially in the life sciences sector. The 4^th economic revolution we are experiencing and participating (consciously or unconsciously) impressed us on the fact that an iphone just a smartphone has become the command and management centre of our lives. Therefore we also use our phones (electronic devices in general) to control, observe and manage our health- life or even health life of our children, relatives and pets. Companies have long noticed this medical-technological trend, but now (also due to the global situation) it has significantly accelerated.

In support of this thesis, we want to submit you a new report (CB Insights report) about the state of telehealth sector and polish, detailed regulation (The Minister of Health ordinance from 12^th August, 2020) about the tele-med-guidance rules.

FIRST PART- TELEHEALTH MARKET RECOVERY

I

The CB INSIGHTS published a report- State Of Telehealth Q2’21 Report: Investment & Sector Trends To Watch which in a very adequate,  professional and analytical way pointes the main global trends in a telehealth economic sector out and uses the examples of the biggest transactions, M&A with extensive use of statistical data, diagrams and schemes.

More

On the 3th July 2021 the amendments of the Rules of Polish Civil Procedure and other statutory laws (especially the statutory law about solutions related to preventing, counteracting and combating COVID- 19) have entered into force.

The Act of the Council of Ministers’ initiative provides for a number of changes in the Polish civil procedure, including:

1. more online hearings,
2. participation of witnesses in remote hearings,
3. examination of the case by a single-judge panel,
4. new procedure for the service of judicial documents,
5. new formality requirement,
6. and other less relevant law changes.

More

PLAN, CAPTURE AND SET THE INFRASTRUCTURE FOR DATA SHARING ACROSS THE VALUE CHAIN, TO OPTIMIZE COMMERCIAL STRATEGY.

On July 29, 2021 KG Legal Kiełtyka Gładkowski will take part in webinar ‘Cell and gene data innovation and multi-stakeholder data transfer’ organized by Reuters as part of the activities of Pharma Boardroom (the global platform for C -level healthcare executives) in partnership with Sales force. This online-conference will focus on the life-changing cell and gene therapies and related with it value chains of these therapies and data transfer between the stakeholders.

More

The 7th Annual General Meeting of the Danish-based international legal organization BioLaw Europe FmbA ended on June 30, 2021. This year the organization held online AGM meeting. During the AGM a new board was elected.

THE 2021/22 BOARD OF DIRECTORS, MANAGEMENT & AUDITOR is composed of:

Mark Anderson, Attorney-at-Law, Chairman & Director.

Christian Dierks, Attorney-at-Law, Vice Chairman & Director.

Sonja Hebenstreit, Attorney-at-Law, Director.

Linda Longo, Attorney-at-Law, Director.

Olivier van Obberghen, Attorney-at-Law, Director.

Jan Bjerrum Bach, Attorney-at-Law, Secretary & Treasurer.

K. Jakub Gładkowski, Attorney-at-Law, Auditor.

BIOLAW EUROPE is a legal organization associating law firms specializing, inter alia, in providing legal services to business entities from the life sciences and pharmaceutical market, including regulatory law in the European Union, for example regarding the legal situation of the most modern medicinal products today, such as advanced therapy medical devices and genetic material engineering.

Full information about BIOLAW EUROPE can be found at:

https://www.jusmedico.com/biolaweurope-f-m-b-a/

More